BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 22247010)

  • 1. Tumour growth inhibition and anti-metastatic activity of a mutated furin-resistant Semaphorin 3E isoform.
    Casazza A; Kigel B; Maione F; Capparuccia L; Kessler O; Giraudo E; Mazzone M; Neufeld G; Tamagnone L
    EMBO Mol Med; 2012 Mar; 4(3):234-50. PubMed ID: 22247010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A SEMA3E mutant resistant to cleavage by furins (UNCL-SEMA3E) inhibits choroidal neovascularization.
    Toledano S; Lu H; Palacio A; Kigel B; Kessler O; Allon G; Barak Y; Neufeld G; Schaal S
    Exp Eye Res; 2016 Dec; 153():186-194. PubMed ID: 27725196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Semaphorin 3d and semaphorin 3e direct endothelial motility through distinct molecular signaling pathways.
    Aghajanian H; Choi C; Ho VC; Gupta M; Singh MK; Epstein JA
    J Biol Chem; 2014 Jun; 289(26):17971-9. PubMed ID: 24825896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of semaphorin as a novel strategy for therapeutic angiogenesis.
    Moriya J; Minamino T; Tateno K; Okada S; Uemura A; Shimizu I; Yokoyama M; Nojima A; Okada M; Koga H; Komuro I
    Circ Res; 2010 Feb; 106(2):391-8. PubMed ID: 19940264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphatidylinositol-4-phosphate 5-kinase and GEP100/Brag2 protein mediate antiangiogenic signaling by semaphorin 3E-plexin-D1 through Arf6 protein.
    Sakurai A; Jian X; Lee CJ; Manavski Y; Chavakis E; Donaldson J; Randazzo PA; Gutkind JS
    J Biol Chem; 2011 Sep; 286(39):34335-45. PubMed ID: 21795701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sema3E-Plexin D1 signaling drives human cancer cell invasiveness and metastatic spreading in mice.
    Casazza A; Finisguerra V; Capparuccia L; Camperi A; Swiercz JM; Rizzolio S; Rolny C; Christensen C; Bertotti A; Sarotto I; Risio M; Trusolino L; Weitz J; Schneider M; Mazzone M; Comoglio PM; Tamagnone L
    J Clin Invest; 2010 Aug; 120(8):2684-98. PubMed ID: 20664171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Semaphorin 3E-Plexin-D1 signaling regulates VEGF function in developmental angiogenesis via a feedback mechanism.
    Kim J; Oh WJ; Gaiano N; Yoshida Y; Gu C
    Genes Dev; 2011 Jul; 25(13):1399-411. PubMed ID: 21724832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sema3E-PlexinD1 signaling selectively suppresses disoriented angiogenesis in ischemic retinopathy in mice.
    Fukushima Y; Okada M; Kataoka H; Hirashima M; Yoshida Y; Mann F; Gomi F; Nishida K; Nishikawa S; Uemura A
    J Clin Invest; 2011 May; 121(5):1974-85. PubMed ID: 21505259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuronal chemorepellent Semaphorin 3E inhibits human airway smooth muscle cell proliferation and migration.
    Movassagh H; Shan L; Halayko AJ; Roth M; Tamm M; Chakir J; Gounni AS
    J Allergy Clin Immunol; 2014 Feb; 133(2):560-7. PubMed ID: 23932461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteolytic processing converts the repelling signal Sema3E into an inducer of invasive growth and lung metastasis.
    Christensen C; Ambartsumian N; Gilestro G; Thomsen B; Comoglio P; Tamagnone L; Guldberg P; Lukanidin E
    Cancer Res; 2005 Jul; 65(14):6167-77. PubMed ID: 16024618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sema3E/PlexinD1 signaling inhibits postischemic angiogenesis by regulating endothelial DLL4 and filopodia formation in a rat model of ischemic stroke.
    Zhou YF; Chen AQ; Wu JH; Mao L; Xia YP; Jin HJ; He QW; Miao QR; Yue ZY; Liu XL; Huang M; Li YN; Hu B
    FASEB J; 2019 Apr; 33(4):4947-4961. PubMed ID: 30653356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Semaphorin 3E expression correlates inversely with Plexin D1 during tumor progression.
    Roodink I; Kats G; van Kempen L; Grunberg M; Maass C; Verrijp K; Raats J; Leenders W
    Am J Pathol; 2008 Dec; 173(6):1873-81. PubMed ID: 18974298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PLXND1/SEMA3E Promotes Epithelial-Mesenchymal Transition Partly via the PI3K/AKT-Signaling Pathway and Induces Heterogenity in Colorectal Cancer.
    Hagihara K; Haraguchi N; Nishimura J; Yasueda A; Fujino S; Ogino T; Takahashi H; Miyoshi N; Uemura M; Matsuda C; Mizushima T; Yamamoto H; Mori M; Doki Y; Eguchi H
    Ann Surg Oncol; 2022 Nov; 29(12):7435-7445. PubMed ID: 35917012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced expression of semaphorin 3E is involved in the gastric cancer development.
    Maejima R; Tamai K; Shiroki T; Yokoyama M; Shibuya R; Nakamura M; Yamaguchi K; Abue M; Oikawa T; Noguchi T; Miura K; Fujiya T; Sato I; Iijima K; Shimosegawa T; Tanaka N; Satoh K
    Int J Oncol; 2016 Sep; 49(3):887-94. PubMed ID: 27572291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PlexinD1 Is a Novel Transcriptional Target and Effector of Notch Signaling in Cancer Cells.
    Rehman M; Gurrapu S; Cagnoni G; Capparuccia L; Tamagnone L
    PLoS One; 2016; 11(10):e0164660. PubMed ID: 27749937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An image-based RNAi screen identifies SH3BP1 as a key effector of Semaphorin 3E-PlexinD1 signaling.
    Tata A; Stoppel DC; Hong S; Ben-Zvi A; Xie T; Gu C
    J Cell Biol; 2014 May; 205(4):573-90. PubMed ID: 24841563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Semaphorin 3E promote Schwann cell proliferation and migration.
    Shen M; Chen Y; Tang W; Ming M; Tian Y; Ding F; Wu H; Ji Y
    Exp Cell Res; 2022 Mar; 412(2):113019. PubMed ID: 35085549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plexin-D1/Semaphorin 3E pathway may contribute to dysregulation of vascular tone control and defective angiogenesis in systemic sclerosis.
    Mazzotta C; Romano E; Bruni C; Manetti M; Lepri G; Bellando-Randone S; Blagojevic J; Ibba-Manneschi L; Matucci-Cerinic M; Guiducci S
    Arthritis Res Ther; 2015 Aug; 17(1):221. PubMed ID: 26292963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Semaphorin 3E initiates antiangiogenic signaling through plexin D1 by regulating Arf6 and R-Ras.
    Sakurai A; Gavard J; Annas-Linhares Y; Basile JR; Amornphimoltham P; Palmby TR; Yagi H; Zhang F; Randazzo PA; Li X; Weigert R; Gutkind JS
    Mol Cell Biol; 2010 Jun; 30(12):3086-98. PubMed ID: 20385769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sema3E/PlexinD1 inhibition is a therapeutic strategy for improving cerebral perfusion and restoring functional loss after stroke in aged rats.
    Zhou YF; Li PC; Wu JH; Haslam JA; Mao L; Xia YP; He QW; Wang XX; Lei H; Lan XL; Miao QR; Yue ZY; Li YN; Hu B
    Neurobiol Aging; 2018 Oct; 70():102-116. PubMed ID: 30007159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.